Schwab D, Raithel M, Hahn E G
Medizinische Klinik I mit Poliklinik, Universität Erlangen-Nürnberg.
Z Gastroenterol. 1998 Nov;36(11):983-95.
High-dose corticosteroids remain the gold standard of therapy in acute Crohn's disease, but is associated with a variety of side effects. Nutritional therapy could be an interesting alternative, but corticosteroids are meant to be significantly superior according to efficacy. Published studies, identified by references, MEDLINE and meta-analysis, were evaluated for efficacy of nutritional therapy in acute Crohn's disease. In 18 evaluable of 38 identified publications, 571 patients were treated with nutritional therapy: 295 received elemental diet, 214 oligopeptide diet and 62 polymeric diet. Remission rates were 60%, 55% and 66% respectively. However, only intention-to-treat-analysis was performed in all the studies. When correcting for patients who really were treated with nutritional therapy, remission rates were substantially better: 73%, 70% and 67% respectively, thus comparable with that of corticosteroids. Positive predictors for successful treatment were stenosing disease and low ESR. Remission seems to last as long as after corticosteroid treatment, when a reinduction diet is performed. Negative aspects of nutritional therapy are poor tolerance and higher costs. Perspectives for the future aim on broadening of indications, improving acceptance (by adjuvant instead of exclusive nutrition, or new flavors) and efficacy by modification of compounds (such as glutamine, omega-3 fatty acids or trace elements) or combination with other therapeutic agents (e.g., mesalamine).
大剂量皮质类固醇仍然是急性克罗恩病治疗的金标准,但会伴有多种副作用。营养疗法可能是一种有趣的替代方法,但皮质类固醇在疗效方面被认为明显更优。通过参考文献、医学文献数据库(MEDLINE)检索及荟萃分析确定的已发表研究,对营养疗法在急性克罗恩病中的疗效进行了评估。在38篇已识别出版物中的18篇可评估文献中,571例患者接受了营养疗法:295例接受要素饮食,214例接受寡肽饮食,62例接受聚合饮食。缓解率分别为60%、55%和66%。然而,所有研究均仅进行了意向性分析。当对真正接受营养疗法的患者进行校正后,缓解率显著提高:分别为73%、70%和67%,因此与皮质类固醇的缓解率相当。成功治疗的阳性预测因素为狭窄性疾病和低血沉率。当进行诱导缓解饮食时,营养疗法的缓解期似乎与皮质类固醇治疗后的缓解期一样长。营养疗法的负面因素是耐受性差和费用较高。未来的展望旨在扩大适应证、提高接受度(通过辅助营养而非单纯营养,或新口味)以及通过改变化合物(如谷氨酰胺、ω-3脂肪酸或微量元素)或与其他治疗药物联合(如美沙拉嗪)来提高疗效。